Barker D F, Denison J C, Atkin C L, Gregory M C
Department of Physiology, University of Utah Research Park, Salt Lake City 84108, USA.
Hum Genet. 1997 May;99(5):681-4. doi: 10.1007/s004390050429.
Mutations in the basement membrane collagen gene COL4A5 cause the progressive renal glomerular nephropathy and typical hearing loss that occur in X-linked Alport syndrome. Nearly all cases involve distinct mutations, as expected for an X-linked disease that significantly reduces the fitness of affected males. A few exceptional COL4A5 mutations appear to be associated with a reduced disease severity and may account for a significant proportion of late-onset Alport syndrome in populations where a founder effect has occurred. The novel mutation reported here, COL4A5 arg1677gln, has been detected in three independently ascertained Ashkenazi-American families, causes a relatively mild form of nephritis with typical onset in the fourth or fifth decade, and may be involved in the etiology of a large proportion of adult-onset hereditary nephritis in Ashkenazi Jews.
基底膜胶原蛋白基因COL4A5的突变会导致进行性肾小球肾病以及X连锁Alport综合征中出现的典型听力损失。几乎所有病例都涉及不同的突变,这对于一种显著降低受影响男性健康状况的X连锁疾病来说是预期的。一些特殊的COL4A5突变似乎与疾病严重程度降低有关,并且可能在发生奠基者效应的人群中占晚发性Alport综合征的很大比例。这里报道的新突变COL4A5 arg1677gln,已在三个独立确定的德系犹太裔美国家庭中检测到,会导致一种相对轻度的肾炎形式,典型发病于第四或第五个十年,并且可能在很大比例的德系犹太成人遗传性肾炎的病因中起作用。